Should I buy Avantor (AVTR) stock or is it too late?

Avantor · Health Care · price $15

⭐ What the most reliable analysts say · those who beat their sector, targets replayed on real prices

⭐ The most reliable of them, either direction: Citigroup — 64% of its targets hit on this sector (125 calls tested). It aims for $11 (-25 %), call made on July 9, 2026, maturing on July 9, 2027 (50 d ago).

The 4 reliable analysts $14.50-0.8 %

The 3 other firms $14-4.2 %

How to read it: the 4 reliable firms are not filtered by optimism — 2 aim above the price, 2 below, hence their $14.50 median. “The 3 others” are the firms that don't pass our reliability filter on this sector.

Firm-by-firm track record on Avantor

Here the hit rate is measured <b>on this stock specifically</b> (matured targets replayed against real prices, minimum 5 calls tested) — the green block above measures reliability <b>across the whole sector</b>, which is the criterion behind JPI selections. “Aims for” = the firm's most recent target on this stock; “—” means it hasn't published one recently.

Firm	% right	Gain vs sector	Calls	Aims for
Citigroup	67 %	+39.7 %	6	$11 -25%
Raymond James	52 %	+7.7 %	21	$16 +10%
Morgan Stanley	44 %	+3.7 %	16	$14 -4%
Goldman Sachs	80 %	-2.2 %	5	$14 -4%
Barclays	36 %	-9.0 %	28	$8 -45%
Wells Fargo	33 %	-9.5 %	12	$16 +10%
Baird	36 %	-12.6 %	14	$17 +16%
Evercore ISI Group	40 %	-14.5 %	10	$14 -4%

In short — Should you invest in Avantor? Is it too late, still worth it? Analysts are split (14% buy, median target $14, i.e. -4%). But it pays virtually no dividend. We give you both sides, with the numbers — not advice.

✅ Reasons to believe

Few solid positives from analysts right now: of 7 ratings, only 1 buys, and the median price target ($14) is -4% below the price ($15). Caution prevails.

⚠️ Reasons to hesitate

Even the most reliable firm on AVTR, Jefferies (100% hit rate, 2 scored calls), only targets $9 (call made on December 17, 2025, maturing on December 17, 2026) (-38%) in its most recent call. The stock may already have run past its target.
The consensus is not unanimous: of 7 ratings, 5 are neutral and 1 is a sell.
Limited upside: the median target is only -4% from the current price.
A 12-month target is not a guaranteed path: the price can fall in the meantime.
No dividend: your return depends only on price appreciation.

The analyst consensus on AVTR

Median target $14 (-4%) · 7 ratings · Hold consensus

Strong Buy00%

Buy114%

Hold571%

Sell114%

Strong Sell00%

⚠️ Information, not investment advice. Past performance does not guarantee future results. Analyst targets on a ~12-month horizon.

Frequently asked questions

Should you invest in Avantor now?

We won't decide for you. The facts: 14% of analysts rate it a buy, median target $14 (-4%), and Jefferies (most reliable on AVTR, 100%) targets $9. Weigh that against valuation. This is not personalized advice.

Is it too late to invest in Avantor?

The stated upside is small: the median target ($14) sits just -4% from the price ($15) (most reliable on AVTR: Jefferies, 100%). The real question isn't "too late" but the price-to-value gap and risk. Not advice.

Is Avantor still worth investing in?

It depends on the gap between the price ($15) and its estimated value: analysts target $14 on median (-4%), with 14% buys (most reliable on AVTR: Jefferies, 100%). Cross-check with their real reliability on AVTR and the cautions above. Information, not advice.

What's the main risk in buying AVTR?

Even the most reliable firm on AVTR, Jefferies (100% hit rate, 2 scored calls), only targets $9 (call made on December 17, 2025, maturing on December 17, 2026) (-38%) in its most recent call. The stock may already have run past its target.

→ Go deeper: the full Avantor profile (consensus, analyst reliability, price target, performance).